Literature DB >> 1522903

Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours.

O Delattre1, J Zucman, B Plougastel, C Desmaze, T Melot, M Peter, H Kovar, I Joubert, P de Jong, G Rouleau.   

Abstract

Ewing's sarcoma and related subtypes of primitive neuroectodermal tumours share a recurrent and specific t(11;22) (q24;q12) chromosome translocation, the breakpoints of which have recently been cloned. Phylogenetically conserved restriction fragments in the vicinity of EWSR1 and EWSR2, the genomic regions where the breakpoints of chromosome 22 and chromosome 11 are, respectively, have allowed identification of transcribed sequences from these regions and has indicated that a hybrid transcript might be generated by the translocation. Here we use these fragments to screen human complementary DNA libraries to show that the translocation alters the open reading frame of an expressed gene on chromosome 22 gene by substituting a sequence encoding a putative RNA-binding domain for that of the DNA-binding domain of the human homologue of murine Fli-1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1522903     DOI: 10.1038/359162a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  525 in total

1.  Dual transforming activities of the FUS (TLS)-ERG leukemia fusion protein conferred by two N-terminal domains of FUS (TLS).

Authors:  H Ichikawa; K Shimizu; R Katsu; M Ohki
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

Review 2.  Diagnosis and classification of the small round-cell tumors of childhood.

Authors:  S L Cohn
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

3.  A method for accurate detection of translocation junctions in Ewing family of tumors.

Authors:  T Morishita; M E Bolander; K Zhang; S Tamai; Y Mii; G Sarkar
Journal:  Mol Biotechnol       Date:  2001-06       Impact factor: 2.695

4.  Direct regulation of BCL-2 by FLI-1 is involved in the survival of FLI-1-transformed erythroblasts.

Authors:  Isabelle Lesault; Christine Tran Quang; Jon Frampton; Jacques Ghysdael
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

5.  Induction of a secreted protein by the myxoid liposarcoma oncogene.

Authors:  M Kuroda; X Wang; J Sok; Y Yin; P Chung; J W Giannotti; K A Jacobs; L J Fitz; P Murtha-Riel; K J Turner; D Ron
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

6.  Male sterility and enhanced radiation sensitivity in TLS(-/-) mice.

Authors:  M Kuroda; J Sok; L Webb; H Baechtold; F Urano; Y Yin; P Chung; D G de Rooij; A Akhmedov; T Ashley; D Ron
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

7.  A novel type of EWS-CHOP fusion gene in two cases of myxoid liposarcoma.

Authors:  Taisuke Hosaka; Yasuaki Nakashima; Katsuyuki Kusuzaki; Hiroaki Murata; Tomitaka Nakayama; Takeharu Nakamata; Tomoki Aoyama; Takeshi Okamoto; Kohichi Nishijo; Nobuhito Araki; Tadao Tsuboyama; Takashi Nakamura; Junya Toguchida
Journal:  J Mol Diagn       Date:  2002-08       Impact factor: 5.568

8.  Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target.

Authors:  Hideo Watanabe; Joshua M Francis; Michele S Woo; Banafsheh Etemad; Wenchu Lin; Daniel F Fries; Shouyong Peng; Eric L Snyder; Purushothama Rao Tata; Francesca Izzo; Anna C Schinzel; Jeonghee Cho; Peter S Hammerman; Roel G Verhaak; William C Hahn; Jayaraj Rajagopal; Tyler Jacks; Matthew Meyerson
Journal:  Genes Dev       Date:  2013-01-15       Impact factor: 11.361

9.  CUS2, a yeast homolog of human Tat-SF1, rescues function of misfolded U2 through an unusual RNA recognition motif.

Authors:  D Yan; R Perriman; H Igel; K J Howe; M Neville; M Ares
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

10.  Herpes simplex virus trans-regulatory protein ICP27 stabilizes and binds to 3' ends of labile mRNA.

Authors:  C R Brown; M S Nakamura; J D Mosca; G S Hayward; S E Straus; L P Perera
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.